EG627853 Inhibitors
Ssxb7, a member of the SSX gene family, emerges as an enigmatic target with a predicted function situated within the extracellular environment, hinting at potential roles in intercellular communication or structural processes. The precise molecular functions of Ssxb7 remain elusive, underscoring the need for comprehensive exploration into its cellular activities. Its predicted involvement in the extracellular milieu suggests potential interactions with signaling pathways crucial for cellular homeostasis and intercellular communication. As part of the SSX gene family, Ssxb7 may contribute to diverse cellular processes, playing a role in the intricate dance of regulatory networks that govern cellular functions.
The endeavor to understand the inhibition of Ssxb7 involves probing into various cellular pathways and processes that could influence its function. Chemical inhibitors targeting AMP-activated protein kinase (AMPK), c-Jun N-terminal kinase (JNK), phosphoinositide 3-kinase (PI3K)/AKT, nuclear factor-kappa B (NF-κB), p38 mitogen-activated protein kinase (MAPK), heat shock protein 90 (HSP90), epidermal growth factor receptor (EGFR), MAPK/ERK, mammalian target of rapamycin (mTOR), bromodomain-containing proteins (BET bromodomain), signal transducer and activator of transcription 3 (STAT3), and the ubiquitin-proteasome pathway present a comprehensive array of potential regulatory links. The interconnectedness of Ssxb7 with these pathways suggests a role in cellular processes such as energy sensing, stress response, and signaling cascades. Inhibition of these pathways may indirectly impact Ssxb7, revealing a complex regulatory network that governs its function within the cellular context. This exploration into potential mechanisms of inhibition not only highlights the complexity of Ssxb7's involvement in cellular activities but also paves the way for further investigations to unravel its specific functions and regulatory connections within cellular networks. The challenge lies in deciphering the intricacies of Ssxb7's cellular functions and understanding how its inhibition, either directly or through pathway modulation, contributes to the broader landscape of cellular regulatory mechanisms.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
GSK 2334470 | 1227911-45-6 | sc-364501 sc-364501A | 10 mg 50 mg | $199.00 $1165.00 | 1 | |
GSK2334470, an AMP-activated protein kinase (AMPK) inhibitor, directly influences cellular energy sensing pathways. By inhibiting AMPK, this compound potentially disrupts cellular energy balance, indirectly impacting Ssxb7, which may be linked to energy-dependent cellular functions or survival mechanisms. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125, a JNK inhibitor, directly influences the c-Jun N-terminal kinase (JNK) pathway. Inhibition of JNK signaling may indirectly affect Ssxb7, as JNK pathways are involved in diverse cellular processes, suggesting a potential regulatory link between JNK signaling and the function of Ssxb7. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a PI3-kinase inhibitor, directly affects the PI3K/AKT pathway. This interference may indirectly inhibit Ssxb7, as the PI3K/AKT pathway is known to regulate processes that could impact the protein's function, suggesting a potential connection between PI3K/AKT signaling and Ssxb7 activity. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082, an NF-κB inhibitor, directly influences the NF-κB signaling pathway. Inhibition of NF-κB may indirectly affect Ssxb7, as NF-κB pathways are implicated in regulating various cellular functions, suggesting a potential regulatory link between NF-κB signaling and the function of Ssxb7. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAPK inhibitor, directly influences the p38 MAPK pathway. Inhibition of this pathway may indirectly affect Ssxb7, as p38 MAPK signaling is implicated in various cellular processes, suggesting a potential regulatory link between p38 MAPK signaling and the function of Ssxb7. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
17-AAG, an HSP90 inhibitor, directly influences heat shock protein 90 (HSP90) pathways. Inhibition of HSP90 may indirectly affect Ssxb7, as HSP90 is involved in the regulation of client proteins involved in various cellular functions, suggesting a potential regulatory link between HSP90 signaling and the function of Ssxb7. | ||||||
Tyrphostin AG 1478 | 175178-82-2 | sc-200613 sc-200613A | 5 mg 25 mg | $96.00 $421.00 | 16 | |
AG1478, an EGFR inhibitor, directly affects the epidermal growth factor receptor (EGFR) pathway. Inhibition of EGFR may indirectly affect Ssxb7, as EGFR pathways are implicated in various cellular processes, suggesting a potential regulatory link between EGFR signaling and the function of Ssxb7. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059, a MEK inhibitor, directly influences the MAPK/ERK pathway. Inhibition of this pathway may indirectly affect Ssxb7, as the MAPK/ERK pathway is implicated in various cellular processes, suggesting a potential regulatory link between MAPK/ERK signaling and the function of Ssxb7. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, a mTOR inhibitor, directly influences the mTOR signaling pathway. Inhibition of mTOR may indirectly affect Ssxb7, as mTOR pathways are implicated in the regulation of cellular processes, suggesting a potential regulatory link between mTOR signaling and the function of Ssxb7. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1, a BET bromodomain inhibitor, directly influences bromodomain-containing protein pathways. Inhibition of BET bromodomain proteins may indirectly affect Ssxb7, as bromodomain-containing proteins are implicated in the regulation of cellular processes, suggesting a potential regulatory link between BET bromodomain signaling and the function of Ssxb7. | ||||||